Latent toxoplasma gondii infection

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funder: Leibniz-Institut für Arbeitsforschung an der TU Dortmund

Humans1

Outcomes

Cellular senescence

no changein humans1

1 study

Latent toxoplasma gondii infection has no effect on cellular senescence in humans.
“latent T. gondii infection did not modify the immunosenescence trend.”
Humansn = 584
Latent Toxoplasma gondii Infection Does Not Modulate Immune Aging in a Cross-Sectional Working-Age Population Study
Biomolecules30 Dec 2025

Associations

IMMAX

upin humans1

1 study

Latent toxoplasma gondii infection is associated with IMMAX in humans.
“Latent T. gondii infection exhibited significant bivariate associations with the composite immune age index IMMAX pointing to accelerated immune aging in seropositive individuals.”
Humansunadjusted bivariate analysisn = 584
Latent Toxoplasma gondii Infection Does Not Modulate Immune Aging in a Cross-Sectional Working-Age Population Study
Biomolecules30 Dec 2025

Latest

1 in 12 months

Biomolecules28 Jan